191 related articles for article (PubMed ID: 15279664)
21. Haematological Effects of Intermittent Pneumatic Compression for Deep Vein Thrombosis Prophylaxis.
Morris RJ; Roberts CH
Thromb Haemost; 2020 Jun; 120(6):912-923. PubMed ID: 32359225
[TBL] [Abstract][Full Text] [Related]
22. The association between seated immobility and local lower-limb venous coagulability in healthy adult volunteers: a simulation of prolonged travel immobility.
Ansari MT; Mahmood MT; Karlberg JP
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):335-41. PubMed ID: 16788308
[TBL] [Abstract][Full Text] [Related]
23. [A case of deep vein thrombosis in spite of using an intermittent pneumatic compression device].
Matsuda T; Inoue S; Sakamoto T; Uji M; Nagai A; Shinjo T; Hirai K; Furuya H
Masui; 2005 Jul; 54(7):805-8. PubMed ID: 16026068
[TBL] [Abstract][Full Text] [Related]
24. The urokinase system in patients with intermittent and persistent allergic rhinitis.
Kasperska-Zajac A; Brzoza Z; Rogala B
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):685-8. PubMed ID: 18832910
[TBL] [Abstract][Full Text] [Related]
25. Mechanical compression in the prophylaxis of venous thromboembolism.
MacLellan DG; Fletcher JP
ANZ J Surg; 2007 Jun; 77(6):418-23. PubMed ID: 17501878
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results.
Jacobs DG; Piotrowski JJ; Hoppensteadt DA; Salvator AE; Fareed J
J Trauma; 1996 May; 40(5):710-16; discussion 716-7. PubMed ID: 8614068
[TBL] [Abstract][Full Text] [Related]
27. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.
Falkenberg M; Holmdahl L; Tjärnström J; Risberg B
Eur J Surg; 2001 Jan; 167(1):10-4. PubMed ID: 11213813
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
[TBL] [Abstract][Full Text] [Related]
29. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
30. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
31. Haemostatic parameters in patients with primitive venous hypertension.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
[TBL] [Abstract][Full Text] [Related]
32. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal fibrinolytic response to various aspects of laparoscopic surgery: a randomized trial.
Brokelman WJ; Holmdahl L; Bergström M; Falk P; Klinkenbijl JH; Reijnen MM
J Surg Res; 2006 Dec; 136(2):309-13. PubMed ID: 17054995
[TBL] [Abstract][Full Text] [Related]
34. Haemostatic changes in patients with deep vein thrombosis.
Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect.
Chouhan VD; Comerota AJ; Sun L; Harada R; Gaughan JP; Rao AK
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2812-7. PubMed ID: 10559031
[TBL] [Abstract][Full Text] [Related]
36. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
[TBL] [Abstract][Full Text] [Related]
37. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
38. Fibrinolysis after application of a pneumatic tourniquet.
Petäjä J; Myllynen P; Myllylä G; Vahtera E
Acta Chir Scand; 1987; 153(11-12):647-51. PubMed ID: 3124428
[TBL] [Abstract][Full Text] [Related]
39. [Changes in fibrinolysis-associated parameters in HELLP syndrome].
Kolben M; Lopens A; Schmitt M; Schneider KT; Graeff H
Geburtshilfe Frauenheilkd; 1994 May; 54(5):257-61. PubMed ID: 8050684
[TBL] [Abstract][Full Text] [Related]
40. Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Kolk A; Pautke C; Horch HH
J Craniomaxillofac Surg; 2005 Jun; 33(3):191-6. PubMed ID: 15878520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]